The International Collaborative Gaucher Group GRAF (Gaucher Risk Assessment for Fracture) score: a composite risk score for assessing adult fracture risk in imiglucerase-treated Gaucher disease type 1 patients.
Patrick DeeganAneal KhanJosé Simon CameloJulie L BatistaNeal WeinrebPublished in: Orphanet journal of rare diseases (2021)
The GRAF score is a tool to be used with bone density and other modifiable, non-GD-specific risk factors (e.g. smoking, alcohol intake, frailty) to inform physicians and previously untreated GD1 patients about risk for a future fracture after starting imiglucerase regardless of whether there is an eventual switch to an alternative ERT or to substrate reduction therapy. GRAF can also help predict the extent that fracture risk increases if initiation of treatment is further delayed.
Keyphrases
- end stage renal disease
- risk assessment
- newly diagnosed
- risk factors
- ejection fraction
- chronic kidney disease
- replacement therapy
- primary care
- prognostic factors
- stem cells
- peritoneal dialysis
- hip fracture
- young adults
- climate change
- postmenopausal women
- heavy metals
- weight loss
- physical activity
- combination therapy
- soft tissue